Download - 4. KANKER ENDOMETRIUM
![Page 1: 4. KANKER ENDOMETRIUM](https://reader036.vdokumen.com/reader036/viewer/2022082319/5695cfa61a28ab9b028ef67c/html5/thumbnails/1.jpg)
KAKANKERNKER ENDOMETRIUM ENDOMETRIUM
Epidemiologi:– Umur: dekade 6-7– Rata-rata: 60 th– Terutama pd menopause, meningkat sesuai
peningkatan umur.– Peran estrogen sangat besar
![Page 2: 4. KANKER ENDOMETRIUM](https://reader036.vdokumen.com/reader036/viewer/2022082319/5695cfa61a28ab9b028ef67c/html5/thumbnails/2.jpg)
PREDISPOSISI:– Nulipara– Infertility, haid tdk teratur– Late menopause (52 th, 2x PP 49 th)– Obesitas (3-10x)– Eksposur estrogen – Estrogen eksogen– DM, Hipertensi– Atipical endometrium hiperplasia (8-29x)
![Page 3: 4. KANKER ENDOMETRIUM](https://reader036.vdokumen.com/reader036/viewer/2022082319/5695cfa61a28ab9b028ef67c/html5/thumbnails/3.jpg)
PATOLOGI:– Adeno carcinoma 60%– Adeno acanthoma 22%– Adeno squamous ca 7%– Clear cell ca 6%– Papillary adeno ca 4%– Secretory ca 1%
GRADING HISTOLOGIS:– G1– G2– G3
![Page 4: 4. KANKER ENDOMETRIUM](https://reader036.vdokumen.com/reader036/viewer/2022082319/5695cfa61a28ab9b028ef67c/html5/thumbnails/4.jpg)
STADIUM KLINIKSTADIUM KLINIK0 : Karsinoma InsituI : Terbatas pd korpus
– IA : Panj cav uteri < 8 cm. G1,G2,G3– IB : Panj cav uteri > 8cm
II : Korpus & serviksIII : Penyebaran keluar uterus, tdk keluar
true pelvisIV : Keluar true pelvis atau mengenai
mukosa kandung kencing / rektum
![Page 5: 4. KANKER ENDOMETRIUM](https://reader036.vdokumen.com/reader036/viewer/2022082319/5695cfa61a28ab9b028ef67c/html5/thumbnails/5.jpg)
PENYEBARANPENYEBARAN
Biasa : lambat, kecuali G3G1 biasa penyebaran permukaan cavum
uteri-endoserviks ( spt penyebaran kanker serviks)
Bila miometrium cepat : limpatik regional, inguinal melalui lig. rotundum
![Page 6: 4. KANKER ENDOMETRIUM](https://reader036.vdokumen.com/reader036/viewer/2022082319/5695cfa61a28ab9b028ef67c/html5/thumbnails/6.jpg)
GAMBARAN KLINIKGAMBARAN KLINIKANAMNESIS:
– Perdarahan abnormal pada klimakterium / menopause atau leukore
– Diskomfort perut bag bawah– sering tanpa keluhan
![Page 7: 4. KANKER ENDOMETRIUM](https://reader036.vdokumen.com/reader036/viewer/2022082319/5695cfa61a28ab9b028ef67c/html5/thumbnails/7.jpg)
PEMERIKSAAN FISIK: – Pada tk awal: normal– Lanjut:
Tanda penyakit daerah sekitarTanda sesuai organ terinfeksi
![Page 8: 4. KANKER ENDOMETRIUM](https://reader036.vdokumen.com/reader036/viewer/2022082319/5695cfa61a28ab9b028ef67c/html5/thumbnails/8.jpg)
PEMERIKSAAN PENUNJANG– Pap smear (30-50% hasil positif)– Endo aspiration biopsi (90-98%, acuvacy)– D&C– Histologis– Lain-lain untuk mengetahui luas penyakit
![Page 9: 4. KANKER ENDOMETRIUM](https://reader036.vdokumen.com/reader036/viewer/2022082319/5695cfa61a28ab9b028ef67c/html5/thumbnails/9.jpg)
DIAGNOSTIK
- Histopatologi
![Page 10: 4. KANKER ENDOMETRIUM](https://reader036.vdokumen.com/reader036/viewer/2022082319/5695cfa61a28ab9b028ef67c/html5/thumbnails/10.jpg)
TERAPITERAPISTD 0-II
– Operasi: Histerektomi + BSO– K/P: Radiasi/Sitostatika/Progesteron
STD III:– Radiasi, Sitostatika, Progesteron
STD IV:– Paliatif
RESIDIF:– Progesteron
![Page 11: 4. KANKER ENDOMETRIUM](https://reader036.vdokumen.com/reader036/viewer/2022082319/5695cfa61a28ab9b028ef67c/html5/thumbnails/11.jpg)
PROGNOSISPROGNOSIS
FIVE YEARS SURVIAL RATE:– STD I: 90 %– STD II: 36-55%– STD III: 25-44%– STD IV: 0-3%